Test of an injected erythropoietin copy in healthy men
This Phase 1 study tests how an injected “copy” version of erythropoietin behaves in the blood in healthy volunteers. It’s mainly about measuring safety and blood-level changes, not treating an illness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult man age 18 to 55
- Your body size must be within set limits (BMI 18 to 29.9, and weight 60 to 100 kg)
- You must be able to read, understand, and sign the consent form
- You must have no signs of illness on checkups (history, physical exam, vital signs, lab tests, and ECG)
- You must test negative for coronavirus
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new erythropoietin (a medicine that helps your body make red blood cells) and compares it to an approved version called Eprex. It is for healthy adults to see how the two medicines work in the body and if they are safe.
This Phase 1 study checks how a “biosimilar” version of filgrastim works in healthy men given under the skin. It mainly aims to compare the body’s response (safety and how the drug behaves) rather than treat a disease.
This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.
This trial tests a new drug called HS-20136-2 in healthy people to see how it works in the body and if it's safe. It's a Phase 1 study to gather early information before testing in patients.
This trial tests a single dose of an experimental medicine called EB070 in healthy people. It checks how the drug moves through the body and if it causes side effects. You may be able to join if you are a generally healthy adult.
This study tests a new experimental drug called NANOKINE alongside an approved drug (Eprex) to see how your body handles them. It is for healthy male volunteers and will help researchers understand how the new drug works and if it is safe.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.